Over the next few weeks, close to 10 drug companies including Abbott, Lupin, Micro Labs, Mcleods Pharma, Cipla, Strides Pharma and Dr Reddy’s Laboratories are expected to launch their own brands of favipiravir, despite inconclusive evidence of its effectiveness.
